Dave RD, Vyasa BM, Daniel PS, Anand IS, Patel CN
Dave RD*, Vyasa BM, Daniel PS, Anand IS and Patel CN
Shri Sarvajanik Pharnacy College, Near Aravind Baug, Mehsana-384001, Gujarat, India.
Volume - 3,
Issue - 3,
Year - 2010
For the treatment of fungal infections, triazoles have been very useful for many years. But, recently many new species of fungal pathogens have been emerged which is a challenging situation now a days. Conventional drug resistant species have also been found that cannot be treated efficiently by the conventional drug therapy. To solve this serious situation, there was a need of potent, efficient and broad spectrum agent which can also treat such conventional resistant and new infections with old fungal pathogens. The answer of all questions have been found as a Posaconazole, a newer azole antifungal which can treat old, new and difficult-to-treat fungal infections. This drug also helps to treat the life threatening conditions caused by fungal infections. This drug show beneficial effects in the immunocompromised patients. So Posaconazole has come up with more promising results than conventional antifungal agents.
Cite this article:
Dave RD, Vyasa BM, Daniel PS, Anand IS, Patel CN. A Review on Posaconazole: A Newer Antifungal. Research J. Pharm. and Tech.3 (3): July-Sept. 2010; Page 694-699.
Dave RD, Vyasa BM, Daniel PS, Anand IS, Patel CN. A Review on Posaconazole: A Newer Antifungal. Research J. Pharm. and Tech.3 (3): July-Sept. 2010; Page 694-699. Available on: https://rjptonline.org/AbstractView.aspx?PID=2010-3-3-2